TERRY JAMES: Open Payments
NPI 1225250640 · ADDISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 24 payments from 5 companies in 2025. Trend: 2023 $14 · 2024 $48 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $183 |
| Novo Nordisk Inc | 1 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Lundbeck LLC | 1 | $16 |
Products named: TRELEGY ELLIPTA, Wegovy, JARDIANCE, FARXIGA, REXULTI, BREZTRI, AREXVY, SHINGRIX.
Industry payments across AL — which companies pay providers there.
